Sam Chun Dang Pharm. Co., Ltd (KOSDAQ: 000250)

South Korea flag South Korea · Delayed Price · Currency is KRW
148,500
+1,500 (1.02%)
Dec 30, 2024, 9:00 AM KST
92.11%
Market Cap 3.45T
Revenue (ttm) 208.22B
Net Income (ttm) 5.11B
Shares Out 23.26M
EPS (ttm) 221.48
PE Ratio 675.85
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 461,294
Open 146,500
Previous Close 147,000
Day's Range 144,700 - 152,300
52-Week Range 61,900 - 230,000
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Feb 7, 2025

About Sam Chun Dang Pharm.

Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, S... [Read more]

Industry Pharmaceutical Preparations
Founded 1943
Employees 409
Stock Exchange KOSDAQ
Ticker Symbol 000250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.